Bipolar Affective Disorder Clinical Trial
Official title:
Effect of Regulated Add -on Sodium Chloride Intake on Stabilization of Serum Lithium Concentration in Bipolar Disorder: A Randomized Controlled Trial
Verified date | January 2022 |
Source | All India Institute of Medical Sciences, Bhubaneswar |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Bipolar affective disorder or manic -depressive psychosis (MDP) is a mood disorder affecting 2.4% of the global population . Lithium is considered as the "gold standard" for the treatment of bipolar disorder but the clinical use of lithium is often restricted due to its narrow therapeutic range and adverse effects. In a published case report, Bleiwiss H found that sodium chloride supplementation diminished the adverse effects caused by lithium The literature search also revealed that till date, there is no published clinical study evaluating the effect of dietary intake of sodium in preventing the fluctuations of serum lithium level and lithium toxicity Therefore, a randomized clinical trial has been designed to evaluate the effect of regulated add -on dietary sodium chloride on serum lithium levels in bipolar disorder.
Status | Completed |
Enrollment | 60 |
Est. completion date | January 7, 2022 |
Est. primary completion date | December 31, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 60 Years |
Eligibility | Inclusion Criteria: - Patients aged 18 -60 years, of either sex with the clinical diagnosis of bipolar disorder (DSM V) who are on maintenance lithium therapy for = 1month and = 6 months. - Patients with normal serum sodium level (135 -145 mEq/L) and serum lithium in the optimum therapeutic range (<0.6 mEq/ L or >0.8 mEq/ L) . Exclusion Criteria: - Patients with comorbidities like other psychiatric disorder s, organicity, substance abuse, personality disorder, intellectual disability and other neurotic disorders . - Patients with any renal, cardiovascular, neurologica l, endocrinal and hepatic dysfunction. - Patients suffering from diarrhoea, dehydration - History of any invasive neurosurgical/ non -invasive neuropsychiatric procedure. - Medication history of psychoactive or central nervous system depressant drugs. - Patients who are on NSAIDs, ACE inhibitors, antiarrhythmics, diuretics and neuromuscular blocking agents . - Pregnant and nursing women . - Patients with drug/alcohol abuse. |
Country | Name | City | State |
---|---|---|---|
India | Aiims Bhubaneswar | Khorda | Orissa |
Lead Sponsor | Collaborator |
---|---|
All India Institute of Medical Sciences, Bhubaneswar |
India,
Bleiweiss H. Salts supplements with lithium. Lancet. 1970 Feb 21;1(7643):416. — View Citation
Demers RG, Heninger GR. Sodium intake and lithium treatment in mania. Am J Psychiatry. 1971 Jul;128(1):100-4. — View Citation
Kessler RC, Ormel J, Petukhova M, McLaughlin KA, Green JG, Russo LJ, Stein DJ, Zaslavsky AM, Aguilar-Gaxiola S, Alonso J, Andrade L, Benjet C, de Girolamo G, de Graaf R, Demyttenaere K, Fayyad J, Haro JM, Hu Cy, Karam A, Lee S, Lepine JP, Matchsinger H, Mihaescu-Pintia C, Posada-Villa J, Sagar R, Ustün TB. Development of lifetime comorbidity in the World Health Organization world mental health surveys. Arch Gen Psychiatry. 2011 Jan;68(1):90-100. doi: 10.1001/archgenpsychiatry.2010.180. — View Citation
Mandal S, Mamidipalli SS, Mukherjee B, Hara SKH. Perspectives, attitude, and practice of lithium prescription among psychiatrists in India. Indian J Psychiatry. 2019 Sep-Oct;61(5):451-456. doi: 10.4103/psychiatry.IndianJPsychiatry_451_18. — View Citation
Merikangas KR, Jin R, He JP, Kessler RC, Lee S, Sampson NA, Viana MC, Andrade LH, Hu C, Karam EG, Ladea M, Medina-Mora ME, Ono Y, Posada-Villa J, Sagar R, Wells JE, Zarkov Z. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011 Mar;68(3):241-51. doi: 10.1001/archgenpsychiatry.2011.12. — View Citation
Murthy RS. National Mental Health Survey of India 2015-2016. Indian J Psychiatry. 2017 Jan-Mar;59(1):21-26. doi: 10.4103/psychiatry.IndianJPsychiatry_102_17. — View Citation
Selvarajan S, Manohar H, Das S, Sakkarabani P, Kandasamy P. Lithium prophylaxis in early-onset Bipolar disorder: a descriptive study. Asian J Psychiatr. 2019 Aug;44:172-174. doi: 10.1016/j.ajp.2019.07.053. Epub 2019 Jul 30. — View Citation
Tomita T, Goto H, Sumiya K, Yoshida T, Tanaka K, Kohda Y. Stabilization of the Serum Lithium Concentration by Regulation of Sodium Chloride Intake: Case Report. Yakugaku Zasshi. 2016;136(3):517-21. doi: 10.1248/yakushi.15-00256. — View Citation
Tondo L, Vázquez GH, Baldessarini RJ. Depression and Mania in Bipolar Disorder. Curr Neuropharmacol. 2017 Apr;15(3):353-358. doi: 10.2174/1570159X14666160606210811. Review. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Difference in percentage of bipolar patients showing fluctuation in serum lithium level | Serum lithium level will be done by electrolyte analyzer. The patients showing fluctuations ( fluctuation is defined as serum lithium <0.6 mEq/ L or >0.8 mEq/ L in maintenance phase) in serum lithium level between the groups over 12 weeks. | 12 weeks | |
Secondary | Serum sodium | Will be done by electrolyte analyzer. | 12 weeks | |
Secondary | Serum Potassium | Will be done by electrolyte analyzer. | 12 weeks | |
Secondary | Serum creatinine | Will be done by autoanalyser. | 12 weeks | |
Secondary | Serum aldosterone | Will be done by commercially available ELISA kit. | 12 weeks | |
Secondary | ECG changes | ECG changes for lithium toxicity (T wave inversion, PR prolongation, QT prolongation), hyponatremia (P wave alterations), hypernatremia (short PR interval and diffuse ST depression) will be looked for | 12 weeks | |
Secondary | Serum Lithium | Will be done by electrolyte analyzer. | 12 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03275714 -
Evaluation of an App for Smartphones for People With a Bipolar Affective Disorder
|
N/A | |
Completed |
NCT03249857 -
Study of Sensorimotor Compatibility Effects in Bipolar Affective Disorder.
|
N/A | |
Completed |
NCT01722344 -
Improving Work Outcome for People With Severe Mental Illness
|
N/A | |
Completed |
NCT01431092 -
Melatonin Versus Placebo for Benzodiazepine Discontinuation in Patients With Schizophrenia
|
Phase 4 | |
Completed |
NCT01315028 -
Bipolar Intervention Study: Cognitive Interpersonal Therapy
|
N/A | |
Terminated |
NCT00805493 -
Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder
|
Phase 2 | |
Completed |
NCT00436020 -
rTMS in the Treatment of Bipolar Depression
|
N/A | |
Withdrawn |
NCT00397605 -
Cannabinoids in Bipolar Affective Disorder
|
N/A | |
Recruiting |
NCT05860101 -
Compassion-Focused Therapy for Distressing Mood Swings: A Case Series
|
N/A | |
Recruiting |
NCT06176456 -
Personalized Prospective Study Evaluation of the Efficacy and Safety of Noninvasive Neuromodulation of TMS in Subjects With Catatonia
|
N/A | |
Terminated |
NCT03310593 -
Cannabidiol as an Adjunctive Treatment for Bipolar Depression
|
Phase 2/Phase 3 | |
Recruiting |
NCT05406414 -
The Efficacy of a Transdiagnostic Sleep and Circadian Intervention for Patients With Mental Disorders and Sleep Problems
|
N/A | |
Completed |
NCT02773108 -
Somatic Comorbidities in Psychiatric Patients
|
||
Recruiting |
NCT00474357 -
Myths About Bipolar Affective Disorder: The Role of Structured Group Psychoeducation Therapy
|
N/A | |
Withdrawn |
NCT00327756 -
Mitochondrial Dysfunction in the Pathophysiology and Treatment of Bipolar Disorder
|
Phase 2 | |
Completed |
NCT02453217 -
The Potential Efficacy of the Chinese Health Improvement Profile- A Pilot Clustered Randomised Controlled Trial
|
N/A | |
Completed |
NCT05683431 -
Using Neuroplasticity-Based Computerized Training to Improve Emotion Regulation in Bipolar Disorder (BRAINS)
|
N/A | |
Not yet recruiting |
NCT05915312 -
Exosome for Early Diagnosis of Bipolar Affective Disorder
|
||
Completed |
NCT00186758 -
Transcranial Magnetic Stimulation in Bipolar Depression
|
Phase 4 | |
Completed |
NCT02083978 -
Bipolar Research Study Using MR Imaging
|
N/A |